These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17273771)

  • 21. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.
    Hino R; Uozaki H; Inoue Y; Shintani Y; Ushiku T; Sakatani T; Takada K; Fukayama M
    Cancer Res; 2008 Mar; 68(5):1427-35. PubMed ID: 18316606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells.
    Zheng JN; Ma TX; Cao JY; Sun XQ; Chen JC; Li W; Wen RM; Sun YF; Pei DS
    Life Sci; 2006 Jan; 78(7):724-9. PubMed ID: 16111722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells.
    Chao JI; Liu HF
    Mol Pharmacol; 2006 Jan; 69(1):154-64. PubMed ID: 16219911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer.
    Yano J; Hirabayashi K; Nakagawa S; Yamaguchi T; Nogawa M; Kashimori I; Naito H; Kitagawa H; Ishiyama K; Ohgi T; Irimura T
    Clin Cancer Res; 2004 Nov; 10(22):7721-6. PubMed ID: 15570006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.
    Han SE; Kang H; Shim GY; Suh MS; Kim SJ; Kim JS; Oh YK
    Int J Pharm; 2008 Apr; 353(1-2):260-9. PubMed ID: 18178348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.
    Kappler M; Bache M; Bartel F; Kotzsch M; Panian M; Würl P; Blümke K; Schmidt H; Meye A; Taubert H
    Cancer Gene Ther; 2004 Mar; 11(3):186-93. PubMed ID: 14739938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Down-regulation of TopI by RNA interference reduces the drug-sensitivity of small cell lung cancer cell lines to topotecan].
    Liu XJ; Guo QS; Zhang Q; Song XR; Liu YL; Guo C
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):741-4. PubMed ID: 19173801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions.
    Kappler M; Rot S; Taubert H; Greither T; Bartel F; Dellas K; Hänsgen G; Trott KR; Bache M
    Cancer Gene Ther; 2007 Dec; 14(12):994-1001. PubMed ID: 17885676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
    Fuessel S; Herrmann J; Ning S; Kotzsch M; Kraemer K; Schmidt U; Hakenberg OW; Wirth MP; Meye A
    Cancer Lett; 2006 Feb; 232(2):243-54. PubMed ID: 16458121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
    Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA; Nikitakis NG; Sauk JJ
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small interfering RNA (siRNA) inhibited human liver cancer cell line SMMC7721 proliferation and tumorigenesis.
    Dong-Dong L
    Hepatogastroenterology; 2007 Sep; 54(78):1731-5. PubMed ID: 18019706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin splice variants regulate the balance between proliferation and cell death.
    Caldas H; Jiang Y; Holloway MP; Fangusaro J; Mahotka C; Conway EM; Altura RA
    Oncogene; 2005 Mar; 24(12):1994-2007. PubMed ID: 15688031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-angiogenesis and anticancer effects of a plasmid expressing both ENDO-VEGI151 and small interfering RNA against survivin.
    Li Z; Yang S; Chang T; Cao X; Shi L; Fang G
    Int J Mol Med; 2012 Mar; 29(3):485-90. PubMed ID: 22109572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
    Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
    Nawrocki ST; Carew JS; Douglas L; Cleveland JL; Humphreys R; Houghton JA
    Cancer Res; 2007 Jul; 67(14):6987-94. PubMed ID: 17638911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells.
    Chen W; Wang X; Zhuang J; Zhang L; Lin Y
    Carcinogenesis; 2007 Oct; 28(10):2114-21. PubMed ID: 17548900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.